Accuray INC

Accuray Incorporated announced a significant financial strengthening plan, including a $55 million financing package with TCW Asset Management Company LLC, and strategic technology collaborations to drive long-term value.

Accuray Incorporated announced the full repayment of its outstanding 3.75% Convertible Senior Notes due 2026, totaling $18 million plus accrued interest.

Accuray Incorporated reported a 7% decrease in third-quarter fiscal 2026 revenue to $104.8 million and withdrew its full-year financial guidance due to geopolitical instability impacting shipments in the Middle East.

Accuray Incorporated announced the departure of its Senior Vice President and Chief Operations Officer, Leonel Peralta, effective April 26, 2026.

Accuray Incorporated has amended its agreement with Dedication Capital to reduce cash compensation by 50% in exchange for accelerated equity vesting.

Accuray Incorporated has appointed medical device veteran Paul Miele as Senior Vice President and Chief Commercial Officer to drive global sales growth.

Accuray Incorporated reported a significant net loss and revenue decline in Q2 2026, driven by reduced product sales and increased interest expenses, despite ongoing restructuring efforts.

Accuray Incorporated filed an amended quarterly report to restate its September 30, 2025 financial information due to errors in remaining performance obligations and identified material weaknesses in internal controls.

Accuray Incorporated reported a significant net loss and revenue decrease in its first fiscal quarter, alongside a major organizational transformation and leadership changes.

Accuray's Q3 2025 shows revenue growth amid ongoing challenges from supply chain issues, inflation, and macroeconomic uncertainties.

Accuray Incorporated reports increased revenue for Q2 FY25, but continues to face challenges from macroeconomic factors and supply chain issues.

Accuray's first quarter results show a net loss and a slight revenue decrease, impacted by supply chain issues and reduced capital spending.

Accuray Incorporated has restated its fiscal year 2025 financial statements and prior interim periods due to errors in remaining performance obligations disclosure and identified material weaknesses in internal controls.

Accuray Incorporated has successfully refinanced its debt, significantly reducing its net loss and achieving positive cash flow from operations, despite ongoing macroeconomic challenges and tariff impacts.

Accuray Incorporated's 10-K filing for fiscal year 2024 details the company's business, financial results, and strategic initiatives in the radiation therapy market.

Accuray Incorporated's Chief Commercial Officer, Paul Miele, was granted 650,000 restricted stock units as part of an equity incentive plan.

TCW Group reports the acquisition of warrants to purchase 3,474,107 shares of Accuray Inc. common stock.

Sandeep Chalke, Accuray's SVP and Chief Commercial Officer, had 40,000 shares withheld for tax obligations related to RSU settlement.

Accuray Inc. Director Steven F. Mayer purchased 54,875 shares of common stock at a weighted average price of $0.5627.

Accuray Director Byron C. Scott reported the acquisition and forfeiture of common stock and the vesting of restricted stock units related to his retirement from the board.

Accuray's SVP Chief Financial Officer, Ali Pervaiz, reported the acquisition and subsequent tax-related disposition of company common stock and restricted stock units.

Accuray Incorporated announced a significant organizational, strategic, and operational transformation, appointing Steve La Neve as CEO and Steven F. Mayer as Transformation Board Sponsor, alongside preliminary Q1 2026 financial results.

Accuray Incorporated announces its 2025 Annual Meeting of Stockholders to vote on director elections, an equity incentive plan, executive compensation, and auditor ratification.

Accuray Incorporated announced its 2025 Annual Meeting of Stockholders will be held virtually on November 13, 2025, to vote on director elections, a new equity incentive plan, executive compensation, and auditor ratification.

Accuray Incorporated has filed a definitive proxy statement with the SEC.

Accuray Incorporated is asking stockholders to approve amendments to its 2016 Equity Incentive Plan and 2007 Employee Stock Purchase Plan at the upcoming Annual Meeting on November 21, 2024.

Accuray Incorporated issued various common stock purchase warrants to TCW Rescue Financing and West Virginia Direct Lending in connection with a delayed draw term loan.

TCW Group, Inc. has increased its beneficial ownership in Accuray Inc. to 11.5% through the issuance of new common stock purchase warrants.

Accuray Incorporated has finalized a new $190 million senior secured credit facility, including term loans and a revolving credit facility, and issued warrants to its lenders, primarily to refinance existing debt and bolster working capital.

Neuberger Berman Group LLC and its affiliates report beneficial ownership of 5.1% of Accuray Inc. common stock as of June 30, 2026.

The Vanguard Group has amended its Schedule 13G filing for Accuray Inc., reporting 0% beneficial ownership following an internal realignment.

The Vanguard Group has reported a 5.13% beneficial ownership stake in Accuray Inc, holding 5,818,576 shares of common stock as of December 31, 2025.

The Vanguard Group reported a 4.86% beneficial ownership in Accuray Inc. common stock as of September 30, 2025, holding 5,476,677 shares.

Aevum Pension Fund reported a 4.86% beneficial ownership stake in Accuray Inc. common stock, holding 5,473,256 shares as of September 30, 2024.

Neuberger Berman Group LLC and its affiliate have disclosed a passive beneficial ownership of 4.7% in Accuray Inc. common stock.